This inventor holds 2 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hyogo, JP (1993)
- Nishinomiya, JP (1993)
Company Filing History:
Years Active: 1993
Certainly! Here is the article about inventor Toshio Yoshioka:
Title: The Innovative Inventor: Toshio Yoshioka
Introduction: Toshio Yoshioka, a brilliant inventor hailing from Hyogo, Japan, has made significant contributions to the field of pharmaceuticals with his groundbreaking inventions.
Latest Patents:
1. Sustained release microcapsule for water soluble drug: Toshio Yoshioka's patent for sustained release microcapsules revolutionizes drug delivery systems, providing a safe and effective method for administering water-soluble drugs with persistent, stable sustained release.
2. Intravascular embolizing agent containing angiogenesis-inhibiting substance: Yoshioka's patent introduces an intravascular embolizing agent that enhances the antitumor effect of angiogenesis-inhibiting substances, reducing doses and side effects while offering strong and long-lasting antitumor effects when used with anti-neoplastic agents.
Career Highlights: Toshio Yoshioka is a key figure at Takeda Chemical Industries, Inc., where his innovative spirit and dedication to research have led to the development of cutting-edge pharmaceutical technologies.
Collaborations: Yoshioka collaborates closely with esteemed colleagues Hiroaki Okada and Shigeru Kamei at Takeda Chemical Industries, Inc., where they work together to push the boundaries of medical advancements and improve patient outcomes.
Conclusion: Toshio Yoshioka's remarkable inventions in the pharmaceutical realm have not only propelled technological advancements but also paved the way for safer and more effective treatment options for patients worldwide. His work continues to inspire future generations of inventors in the pursuit of innovation and excellence.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
